Ipca Laboratories Limited (NSE:IPCALAB)
India flag India · Delayed Price · Currency is INR
1,905.00
-33.40 (-1.72%)
Nov 12, 2026, 3:29 PM IST

Ipca Laboratories Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
2,6544,3711,6722,08912,5792,752
Short-Term Investments
8,4551,2501,745851.35,9503,657
Trading Asset Securities
-6,3347,6345,5843,2337,193
Cash & Short-Term Investments
11,10911,95611,0518,52421,76113,602
Cash Growth
-11.48%8.19%29.63%-60.83%59.98%79.24%
Accounts Receivable
23,95120,14318,84116,9469,9619,180
Other Receivables
-2,0542,5682,0121,8652,088
Receivables
24,43122,69521,83719,05211,85911,372
Inventory
29,37827,31025,60424,71317,43418,580
Prepaid Expenses
-620.3573.1482.9311.9188.6
Other Current Assets
4,3531,1883,6202,617527.1829.7
Total Current Assets
69,27163,76962,68555,38951,89344,572
Property, Plant & Equipment
53,76952,02246,85146,63126,94625,026
Long-Term Investments
2,0942,1012,1633,0363,0272,699
Goodwill
828.1828.1905.8905.8381.4388.4
Other Intangible Assets
1,1121,1481,1271,4261,5911,672
Long-Term Deferred Tax Assets
232.4205.4169.242.335.720.2
Other Long-Term Assets
3,9703,4843,3812,6971,2321,144
Total Assets
131,329123,702117,606111,01386,26476,235

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
10,7449,4038,4627,7615,2515,577
Accrued Expenses
-3,4213,2163,8002,0512,278
Short-Term Debt
-4,1754,9535,5926,6183,678
Current Portion of Long-Term Debt
5,5891,7732,6322,4791,439282.5
Current Portion of Leases
197179.3101.4109.366.644.8
Current Income Taxes Payable
754.2686.6575462253.2183.3
Current Unearned Revenue
-191.2154.7168.7274267.7
Other Current Liabilities
6,7853,2403,7693,1842,1052,347
Total Current Liabilities
24,06923,06923,86223,55618,05814,659
Long-Term Debt
673.51,0915,4325,8046,5183,952
Long-Term Leases
1,068868.9509399.3170.8115
Long-Term Unearned Revenue
---1.22.84.3
Pension & Post-Retirement Benefits
-71.4119.589.716.713.9
Long-Term Deferred Tax Liabilities
2,7352,4492,9503,1051,8921,644
Other Long-Term Liabilities
1,046911.9850787.4453.2430.1
Total Liabilities
29,59228,46133,72333,74327,11120,818

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
253.7253.7253.7253.7253.7253.7
Additional Paid-In Capital
-965.2965.2965.2965.2965.2
Retained Earnings
-79,47368,42462,10457,15153,471
Comprehensive Income & Other
86,530-53.7-158.2-150.7-41.6
Total Common Equity
86,78380,63869,48563,32258,42054,648
Minority Interest
14,95414,60314,39813,948733769.2
Shareholders' Equity
101,73795,24183,88377,27059,15355,418
Total Liabilities & Equity
131,329123,702117,606111,01386,26476,235

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
7,5288,08813,62714,38414,8138,072
Net Cash (Debt)
3,5823,868-2,577-5,8596,9495,530
Net Cash Growth
----25.65%12.06%
Net Cash Per Share
13.8415.25-10.16-23.0927.3921.80
Filing Date Shares Outstanding
245.34253.7253.7253.7253.7253.7
Total Common Shares Outstanding
245.34253.7253.7253.7253.7253.7
Working Capital
45,20240,69938,82331,83333,83529,913
Book Value Per Share
353.72317.84273.88249.59230.27215.40
Tangible Book Value
84,84378,66267,45260,99056,44852,588
Tangible Book Value Per Share
345.81310.06265.87240.40222.49207.28
Land
-3,1593,0756,4252,1452,157
Buildings
-15,58514,43213,5698,1757,140
Machinery
-51,91746,68743,73729,45424,473
Construction In Progress
-7,6166,1623,2361,2222,939
Leasehold Improvements
-17.212.8-7.9-